US Patent Litigations are now available. Check here

Explore Disphar's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2611429Feb 21, 2018Mesalazine Tablet Having Improved Dissolution1